Health
Peptides may soon be easier to get amid RFK Jr’s push, but experts warn of risks
NEWYou can now listen to Fox News articles!
The Food and Drug Administration (FDA) will reportedly weigh easing restrictions on peptides in anticipated talks.
The meeting, which is expected to be held in July, will discuss relaxing limits on more than a half dozen peptide injections.
Peptides are short chains of amino acids — the building blocks of proteins — that play key roles in biological functions, according to the National Institutes of Health. Peptide drugs are lab-made versions of natural molecules in the body that are designed to mimic or influence biological signals to treat disease, experts say.
PARALYZED MAN WALKS AGAIN AFTER EXPERIMENTAL DRUG TRIAL TRIGGERS REMARKABLE RECOVERY
In a federal notice released Wednesday, the FDA identified these drugs — used for conditions ranging from insomnia to obesity — for potential inclusion on a list of substances that can be safely compounded by pharmacies.
Human Services Secretary Robert F. Kennedy Jr. does pull-ups during a conference at Ronald Reagan Washington National Airport in Arlington, Va., on Dec. 8, 2025, discussing the launch of the “Make Travel Family Friendly Again” campaign. (Heather Diehl/Getty Images)
This follows Health and Human Services Secretary Robert F. Kennedy Jr.’s push to deregulate peptides, which he’s spoken about publicly, although most peptides have not been reviewed for safety by the FDA.
Kennedy has discussed using the substances for personal injuries. In a recent interview on “The Joe Rogan Experience” podcast, he stated that he’s a “big fan of peptides.”
ARE PEPTIDES THE FOUNTAIN OF YOUTH? DOCTORS WARN HYPE MAY OUTPACE SCIENCE
The HHS secretary mentioned that he’s “very anxious” to making some peptides “more accessible.”
“My hope is that they will get moved to a place where people have access from ethical suppliers,” Kennedy said, alluding to the FDA taking action.
What to know about peptides
Peptides have gained popularity among wellness influencers and fitness gurus as a means of building muscle, healing injuries or appearing younger, the AP reported.
CLICK HERE FOR MORE HEALTH STORIES
Peptides act like a signal to hormones and the human body. Similar to how GLP-1s (glucagon-like peptide-1 agonists), such as Ozempic, suppress appetite and trigger weight loss, peptides can signal other functions, like the release of growth hormones.
Peptides have gained popularity for outcomes like building muscle, healing injuries or appearing younger, the AP reported. (iStock)
Certain peptides up for review by the FDA, like BPC-157, are marketed for tendon healing, gut healing (in cases like ulcerative colitis), injury recovery and inflammation reduction, although the FDA has warned about the risk of unapproved peptide treatments.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The FDA wrote in a February advisory that “compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.”
“Patients should obtain a prescription from their doctor and fill the prescription at a state-licensed pharmacy,” the agency wrote.
The FDA wrote in a February advisory that “compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug.” (Sarah Silbiger/Getty Images)
The current peptide market has been referred to as the “Wild West” due to lack of regulation. In an interview with AP, Dr. Peter Lurie, a former FDA official who now leads the Center for Science in the Public Interest in Washington, D.C., commented that “the Wild West is about to become wilder.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“I don’t see why one would take the path of proper drug approval if there is now this less rigorous, alternative path to market,” he said.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Under the Biden administration, the FDA added nearly 20 peptides to a list of substances that should not be produced by compounding pharmacies, according to the AP.
The panel of pharmacy advisers at the time noted that the peptides did not meet criteria for safety.
NEWYou can now listen to Fox News articles!
Eliminating sugar from your diet may seem like the key to healthy eating, but research suggests it could have unintended effects on digestive health.
A study presented at ENDO 2026, the Endocrine Society’s annual meeting, suggests that a total lack of sucrose, or table sugar, may harm gut health and disrupt the body’s natural metabolism.
To explore how the total absence of dietary sugar impacts the body, researchers at the Dasman Diabetes Institute in Kuwait City conducted a 16-week study on two groups of mice. Both groups were placed on a low-fat diet, but with one critical difference.
COMMON CHEMICALS FROM FOOD ADDITIVES TO PESTICIDES MAY BE WRECKING YOUR GUT HEALTH, STUDY SAYS
One group consumed a low-fat diet that included a standard amount of sucrose, while the other group ate a low-fat diet that was completely sugar-free, according to the study’s press release.
Throughout the trial, the scientists monitored a wide variety of physiological factors, including the animals’ weight, glucose tolerance, insulin sensitivity, hormone levels, internal inflammation and the specific composition of their gut bacteria.
A total lack of dietary sugar can cause imbalances in the gut bacteria and lead to signs of fatty liver disease, even without any weight gain, researchers said. (iStock)
The study outcome suggested that completely removing sugar caused several unexpected health problems.
“Completely removing sucrose from a low-fat diet may unexpectedly disrupt gut health and promote inflammation and metabolic dysfunction,” Rasheed Ahmad, principal scientist and head of the Immunology & Microbiology Department at the Dasman Diabetes Institute, said in the release.
AMERICANS’ HIGH SUGAR CONSUMPTION PROMPTS URGENT WARNING FROM HEALTH LEADERS
Even though the mice on the sugar-free diet did not gain any extra weight compared to the control group, their internal health indicators deteriorated.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The animals that lacked sucrose developed an imbalance in their gut microbes and increased inflammation within the intestines and liver.
They also showed signs of poor glucose regulation, insulin resistance and cellular changes associated with fatty liver disease, according to the research.
Future dietary guidelines may shift away from strict, absolute sugar bans and instead focus on overall gut health through balanced nutrition. (iStock)
“The findings suggest that complete removal of sucrose from a low-fat diet may negatively affect gut microbiota and metabolic health,” Ahmad concluded.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
While the risks of high-sugar diets are well-established, the researchers noted that little attention has been given to the effects of completely eliminating sugar from low-fat meals.
Scientists say these new findings highlight that dietary carbohydrates play a valuable role in supporting balance between the immune system and the gut microbiome.
Completely cutting sucrose from a low-fat diet can unexpectedly trigger gut inflammation and disrupt the metabolism, experts say. (iStock)
Because this research was conducted on mice over a relatively short 16-week period, further clinical trials are necessary to determine whether a completely sugar-free diet causes the same gut and liver inflammation in humans.
CLICK HERE FOR MORE HEALTH STORIES
Additionally, the study focused specifically on removing sucrose from low-fat meals, meaning the results might not apply to people eliminating sugar while following higher-fat or ketogenic eating plans, the researchers noted.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
The team believes that future dietary guidelines may shift away from strict, absolute sugar restrictions and instead place a greater emphasis on maintaining a diverse, healthy population of gut bacteria through balanced nutrition.
“In the long term, these findings could help improve strategies for preventing and managing metabolic disorders, fatty liver disease and chronic inflammatory conditions,” Ahmad said.
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
NEWYou can now listen to Fox News articles!
A cure for cancer could be on the horizon in the next decade, according to experts.
During the WSJ Leadership Institute CEO Summit in London last week, Johnson & Johnson Chairman and CEO Joaquin Duato reflected on the pharmaceutical company’s projections on the future of cancer treatment.
In the next 10 years, the goal is to “try to eliminate cancer,” Duato shared.
NEW CANCER VACCINE DELIVERS STUNNING RESULT AGAINST ONE OF THE DEADLIEST SKIN CANCERS
“That’s a high goal, and we are already making significant progress in certain cancers,” he said.
Duato used multiple myeloma as an example, noting that the life expectancy is currently 10 years, when it was previously “only single years.”
Joaquin Duato, chairman and CEO of Johnson and Johnson, speaks at the Punchbowl News Conference at Union Station on March 10, 2026, in Washington, DC. (Heather Diehl/Getty Images)
“We have treatments now that utilize your own immune system to attack the cancer,” he said at the summit. “For patients who were already going into hospice, so they didn’t have any other alternative, they are [at] more than five years, with a single administration, in remission. That [is] spectacular.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“When patients see that, they cannot believe that because they have been coming to the hospital every week [for] a decade, having multiple therapies.”
The goal is to “try to eliminate cancer” in the next 10 years, the pharmaceutical executive said. (iStock)
According to Duato, Johnson & Johnson is working to understand the biology of cancer growth and to formulate new technologies to address it.
“It’s realistic to believe that we are going to cure certain cancers, and some others we’re going to turn into chronic diseases,” he predicted.
CLICK HERE FOR MORE HEALTH STORIES
“Cancer is an important thing – I cannot think about anybody who has not been touched by cancer,” he went on. “But there are many other opportunities for us to actually advance science, to address very important social problems.”
Duato called out dementia as another “important problem” in need of a solution.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
He predicted that life expectancy, which has risen steadily over the past century, will continue to increase as longevity technologies and solutions advance, improving quality of life along the way.
Duato commented that J&J has been optimistic about the role artificial intelligence will play in the future of healthcare, calling it a “force multiplier.”
Biomarkers and AI can help with the earlier diagnosis of cancer, as well as a more advanced and personalized approach to surgery, a doctor noted. (iStock)
Fox News senior medical analyst Dr. Marc Siegel agreed with Duato’s outlook on the future of cancer care, noting that certain cancers will turn into chronic diseases while others will find outright cures.
“Advances [will be] based on the use of AI to help guide targeted treatments with expanding knowledge of cancer mutations and how to target them,” he predicted, speaking to Fox News Digital.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Siegel added that biomarkers and AI can help with earlier diagnoses, as well as a more advanced and personalized approach to surgery.
J&J recently acquired Firefly Bio, a biotech firm that produces drugs that enter cancer cells to “target certain proteins that contain difficult to treat gene mutations,” the doctor added.
-
News20 minutes agoGOP Rep. Tom Kean, missing from Congress for months, set to return on June 30
-
Los Angeles, Ca2 hours agoComedian to face charges in first case from L.A. County tax fraud unit
-
Detroit, MI2 hours agoDetroit archdiocese releases last proposed parish Mass stoppages. List hits 90
-
San Francisco, CA2 hours ago
Morning Report: McKivitz Highlights Special Connection to SF 🗞️
-
Dallas, TX2 hours agoFOX’s Kasper Schmeichel compares England to Dallas Cowboys, so who are their other sports analogs?
-
Miami, FL2 hours agoMiami ‘At the Top’ for Star In-State 2028 Running Back
-
Boston, MA2 hours ago
Boston Bruins are retiring Patrice Bergeron’s No. 37 next season
-
Denver, CO3 hours agoBroncos make decision on tryout quarterback, sign 2 players
